ACEP // Laboratory Abnormalities
Assessing the importance of interleukin-6 in COVID-19 – Authors' reply - The Lancet Respiratory Medicine
Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome | European Respiratory Society
The host response in different aetiologies of community-acquired pneumonia - eBioMedicine
IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections | PLOS Pathogens
Combining IL-6 and SARS-CoV-2 RNAaemia-based risk stratification for fatal outcomes of COVID-19 | PLOS ONE
COVID | Free Full-Text | Follow-up of Interleukin 6 and Other Blood Markers during the Hospitalization of COVID-19 Patients: A Single-Center Study
The role of Interleukin 6 inhibitors in therapy of severe COVID-19 - ScienceDirect
The role of Interleukin 6 inhibitors in therapy of severe COVID-19 - ScienceDirect
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity | European Respiratory Society
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
Interleukin-6 and C-reactive protein/albumin ratio as predictors of COVID-19 severity and mortality | The Egyptian Journal of Bronchology | Full Text
Outlook of IL-6 signaling blockade for COVID-19 pneumonia | Inflammation and Regeneration | Full Text
Circulating interleukin 6 and interleukin 10 in community acquired pneumonia | Thorax
Toward the Rapid Diagnosis of Sepsis: Detecting Interleukin-6 in Blood Plasma Using Functionalized Screen-Printed Electrodes with a Thermal Detection Methodology | Analytical Chemistry
Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019 | Cellular & Molecular Immunology
An inflammatory cytokine signature predicts COVID-19 severity and survival | Nature Medicine
Modifications of IL-6 by Hypochlorous Acids: Effects on Receptor Binding | ACS Omega
COVID | Free Full-Text | Follow-up of Interleukin 6 and Other Blood Markers during the Hospitalization of COVID-19 Patients: A Single-Center Study
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters | Nature Communications
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 | Science Immunology
Frontiers | Future Biomarkers for Infection and Inflammation in Febrile Children
Frontiers | Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
